ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Group Chairs Respond to Center Directors’ White Paper

April 1, 2011

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999

Cancer Centers: John Glick to step down after 21 years directing Penn’s Abramson Cancer Center.

December 2, 2005

In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor

January 6, 1989

Bill Planned To Okay Medicare/Medicaid Payment For 100% Of Outpatient Anticancer Drug Costs

February 16, 1979

The Tivozanib Timeline

May 10, 2013